Christos Kyratsous

Christos Kyratsous

Regeneron Pharmaceuticals Inc - Warsaw / United States
Others
AD Scientific Index ID: 4414343
-
person_outline Christos Kyratsous's MOST POPULAR ARTICLES
1-) Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7P Wang, MS Nair, L Liu, S Iketani, Y Luo, Y Guo, M Wang, J Yu, B Zhang, ...Nature 593 (7857), 130-135, 202117892021
2-) COVID-19 vaccine BNT162b1 elicits human antibody and TH 1 T cell responsesU Sahin, A Muik, E Derhovanessian, I Vogler, LM Kranz, M Vormehr, ...Nature 586 (7830), 594-599, 202014252020
3-) REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, ...New England Journal of Medicine 384 (3), 238-251, 202114182021
4-) Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodiesA Baum, BO Fulton, E Wloga, R Copin, KE Pascal, V Russo, S Giordano, ...Science 369 (6506), 1014-1018, 202013702020
5-) CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosisJD Gillmore, E Gane, J Taubel, J Kao, M Fontana, ML Maitland, J Seitzer, ...New England Journal of Medicine 385 (6), 493-502, 202112362021